Qian is a fourth-year PhD student from RMIT University. She is passionate about understanding the complex relationship between diet, health, and brain function. Her research focuses on how Type 2 diabetes affects cognitive abilities like memory and thinking, and explores potential treatments to help improve these functions.

Alexis is a Research Fellow at the Charles Perkins Centre, University of Sydney, investigating how mitochondria and lipids regulate metabolism and insulin resistance. Over the past four years, he has developed novel techniques to study insulin sensitivity and explored the interplay between ceramides and mitochondria in skeletal muscle.

Carys Campbell graduated from the UTS in 2022 with a Bachelor of Medical Science and completed an Honours (Class I) project with UNSW from 2023-2024. Carys currently works as a research assistant with the University of Sydney, and her work focusses on pregnancy, obesity and diabetes.

Cassandra Robertson is an Accredited Practising Dietitian and Credentialed Diabetes Educator at Macintyre Health. She is presenting findings from her Master of Medical Research through Griffith University, which explored the cardioprotective effects of semaglutide versus pravastatin in an ischaemia-reperfusion injury model. Cassandra integrates clinical expertise with translational research in metabolic health.

Dr. Longfield is a postdoctoral researcher working in A/Prof. Glastras' team at the Kolling institute. Her research focuses on adverse outcome prediction in the context of diabetes, obesity and pregnancy. Dr. Longfield's work spans both clinical and basic science research with a strong focus on diabetes-related translational medicine.

Darren is an Associate Professor in Health and Human Performance at UTAS. His research focuses on using pre-clinical models of insulin resistance, diabetes and obesity to study metabolic phenotypes, pathways and processes. His research is focused on understanding mitochondrial and whole-body metabolic dysfunction and identifying targets to treat these conditions.

Carsten Schmitz-Peiffer investigates the mechanisms by which lipid oversupply interferes with insulin action, focussing on the role of protein kinase C. He recently moved to the University of Sydney, where he is investigating the potential targeting of protein kinase C for the treatment of type 2 diabetes

As a renal scientist, Dr. Jha contributions to diabetes and kidney disease research are exceptional. Beginning with his PhD, where he identified the NOX pathway and translated his findings into clinical studies, he continues to lead projects aimed at discovering novel therapeutic targets and biomarkers for diabetes and kidney disease.